Blood · 2018 · 66 citations · 11 references
PharmacyHematologyImmunologyAntibody EngineeringCancer ImmunologyMonoclonal AntibodiesAntibody CharacterizationFalse PositivesImmunogenicity Of Therapeutic AntibodiesMonoclonal Antibody TechnologyMonoclonal Antibody TherapyTherapeutic Monoclonal AntibodiesMonoclonal Antibodies In CancerMonoclonal Antibody CharacterizationMonoclonal Antibody Therapeutics
TO THE EDITOR: Multiple myeloma (MM) is a malignant plasma cell disorder resulting in expansion of clonal plasma cells that encode for a unique monoclonal immunoglobulin (M-protein). The M-protein is derived from recombination and somatic hypermutation events occurring at both the heavy- and light-
11
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text